FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to diagnostics. Training data are received from part of group of patients. Set of solution trees are adjusted on training data. Patient data are received from one or more patients of group, patient data therein are independent from training data. Any patient data are classified using adjusted set of solution trees for obtaining threshold values for patient. Threshold value of patient represents number of solution trees in adjusted set of solution trees, which can classify patient with mild cognitive impairment as passing to Alzheimer's disease. Method is implemented by means of computer.
EFFECT: group of inventions allows early detection of Alzheimer's disease.
15 cl, 2 tbl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TROPOMYOSIN ISOFORMS RELATED TO ALZHEIMER'S DISEASE AND MODERATE COGNITIVE IMPAIRMENTS | 2013 |
|
RU2661022C2 |
| METHOD OF DIAGNOSTICS OF NEURODEGENERATIVE DISEASES | 2011 |
|
RU2567665C2 |
| METHODS OF TREATING ALZHEIMER'S DISEASE | 2015 |
|
RU2720468C2 |
| DRUG FOR PREVENTION OR TREATMENT OF TAUPATHY | 2018 |
|
RU2739199C1 |
| MICRO-RNA-BIOMARKERS INDICATING ALZHEIMER'S DISEASE | 2012 |
|
RU2639509C2 |
| MEMANTINE THERAPY FOR ALZHEIMER'S DISEASE OF LOW AND LOW TO MODERATE SEVERITY | 2005 |
|
RU2371173C2 |
| BIOMARKER AND METHODS FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE | 2015 |
|
RU2687272C2 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ALZHEIMER'S DISEASE USING A PANEL OF BLOOD PROTEINS | 2021 |
|
RU2794040C1 |
| METHODS FOR COGNITIVE FUNCTION SUPPORT, TREATMENT OR IMPROVEMENT | 2013 |
|
RU2635522C2 |
| USE OF LOW-VOLUME PLASMAPHERESIS FOR THE TREATMENT OF EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE | 2019 |
|
RU2802628C2 |
